IMPLANET overview

Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME equity savings plans), a medical technology company specializing in vertebral implants for orthopedic surgery and the distribution of technological medical equipment, today announced its revenue for the first half of 2023. Ludovic Lastennet, IMPLANET’s CEO , stated: “ Implanet recorded stable revenue in the first half of 2023 compared with the same period of 2022, but the semester was marked by determined...

Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME equity savings plans), a medical technology company specializing in implants for orthopedic surgery and the distribution of technological medical equipment, today announced the launch of the MIS range, a minimally invasive pedicle screw positioning system, a result of joint developments with its partner Sanyou Medical. Ludovic Lastennet, Implanet’s CEO, commented : “ With the launch of this range of...

Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME equity savings plans), a medical technology company specializing in vertebral implants for orthopedic surgery and the distribution of technological medical equipment, informs its shareholders that its Annual General Meeting was held on Wednesday May 3, 2023, at 2:00 pm CEST at the Company's registered office, in Martillac. The number of shares held by the shareholders present or represented was 17,113,846,...

Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME equity savings plans), a medical technology company specializing in vertebral implants for orthopedic surgery and the distribution of technological medical equipment, today announces its revenue for the first quarter of 2023. Ludovic Lastennet, IMPLANET’s CEO , stated: “ Our first quarter saw a continuation of the good sales momentum observed since the beginning of 2022. Although activity in France and...

Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME equity savings plans) (Paris:ALIMP), a medical technology company specializing in vertebral implants and the distribution of technological medical equipment, today announced the Food and Drug Administration ( FDA) 510(k) clearance of its Squale TM anterior cervical cage. The Squale TM anterior cervical cage, from the OSD product portfolio, features a wide range of implants a design adapted to vertebral anatomy...

Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME equity savings plans) (Paris:ALIMP), a medical technology company specializing in vertebral implants, today announced its 2022 annual revenue and its cash position at December 31, 2022. Ludovic Lastennet, IMPLANET’s Chief Executive Officer , stated: “ We ended 2022 with a strong overseas performance. Despite the slowdown we are currently experiencing on the French market, we recorded a solid financial year...

Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME equity savings plans) (Paris:ALIMP), a medical technology company specializing in vertebral implants, today announces its schedule for the publication of financial information for 2023Etats-Unis de son expansion commerciale aux Etats-Unis,. Event Dates* 2022 Full-Year Revenue January 24, 2023 2022 Full-Year Results March 7, 2023 Annual General Meeting April 18, 2023 2023 First-Quarter Revenue April 25, 2023...

Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME equity savings plans) (Paris:ALIMP), a medical technology company specializing in vertebral implants, today announces the signing of an agreement with SMTP Technology Co., a high-tech medical device company specialized in the manufacturing and marketing of ultrasonic medical equipment, for the exclusive distribution of its latest generation ultrasonic surgical scalpel in France. Adam Li, GMA & International...